The emerging pandemic of obesity and diabetes: Are we doing enough to prevent a disaster?

International Journal of Clinical Practice

Volumn 60, Issue 9, 2006, Pages 1093-1097

  Naser, Kamal A ^a,c   Gruber, A ^b   Thomson, G A ^a  

^a SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c KING S MILL HOSPITAL   (United Kingdom)

Author keywords

Body mass index; Insulin resistance; Obesity; Type 2 diabetes; Waist circumference; Waist hip ratio

Indexed keywords

METFORMIN;

AGE DISTRIBUTION; ASIAN; BEHAVIOR MODIFICATION; BODY MASS; CARDIOVASCULAR DISEASE; DEATH; DEVELOPING COUNTRY; DIABETES MELLITUS; DISASTER; DISEASE ASSOCIATION; EPIDEMIC; ETHNOLOGY; GENDER BIAS; GEOGRAPHIC DISTRIBUTION; HEALTH BEHAVIOR; HUMAN; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOUTHEAST ASIA; UNITED KINGDOM; UNITED STATES; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADOLESCENT; ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; OBESITY; PREVALENCE; WORLD HEALTH;

EID: 33747157164     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01003.x     Document Type: Review

References (60)

1. Conti CR. Another pill for weight reduction. Clin Cardiol 2005; 28: 59-60.
2. World Health Organisation. Obesity: Preventing and managing the global epidemic. WHO Tech Rep Ser 2000; 894: 1-253.
3. Lean M, Han T, Seidell JC. Impairment of health and quality of life in people with large waist circumference. Lancet 1998; 351: 853-6.
4. Gray DS. Diagnosis and prevalence of obesity. Med Clin North Am 1989; 73: 1-13.
5. Lew EA, Garfinkel L. Variation in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32: 563-76.
6. Brown DW, Balluz LS, Giles WH et al. Diabetes mellitus and health related quality of life among older adults. Findings from Behavioural Risk Factor Surveillance System (BRFSS). Diabetes Res Clin Pract 2004; 65: 105-15.
7. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004; 291: 1238-45.
8. Speakman JR. Obesity part one - the greatest health threat facing mankind. Biologist 2003; 50: 1-5.
9. House of Commons Health Committee. Obesity-third Report Session 2003-04, Vol. 1. Norwich: House of Commons Health Committee, 2004.
10. Joint Health Surveys Unit on behalf of the Department of Health. Health Survey for England: Cardiovascular Disease 98 (The Stationary Office) in National Audit Office, 'Tackling Obesity in England'. Report by the Comptroller and Auditor General, HC 220 Session 2000-2001: 15 February 2001, The Stationary Office Ltd, Norwich, UK 2001.
11. National Centre for Social Research. Health Survey for England 2003. Volume 2: Risk Factors for Cardiovascular Disease. 2004: National Centre for Social Research, The Stationary Office Ltd, Norwich, UK.
12. Walker A. The Cost of Doing Nothing: The Economics of Obesity in Scotland. National Obesity Forum, Glasgow, UK 2003: 7-8. (http://www.cybermedicalcollege.com/Assets/Acrobat/obesitycosts.pdf).
13. Ford ES, Kohl HW, Mokdad AH, Ajani UA. Sedentary behaviour, physical activity, and the metabolic syndrome among US adults. Obes Res 2005; 13: 608-14.
14. Genuth SM, Bennett PH, Miller M, Burch TA. Hyperinsulinism in obese diabetic Pima Indians. Metabolism 1967; 16: 1010-5.
15. Colditz GA, Willett WC, Stampfer MJ et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-13.
16. Hu FB, Li TY, Colditz GA, Willett WC, Manson JAE. Television watching and other sedentary behaviours in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003; 289: 1785-91.
17. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes and obesity related health risk factors 2001. JAMA 2001; 289: 76-9.
18. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of non-insulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: A 7-year prospective study. Obes Res 1997; 5: 16-23.
19. Field AE, Coakley EH, Must A et al. Impact of over weight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161: 1581-6.
20. Colditz GA, Willett WC, Stampfer MJ et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-13.
21. Hu FB, Manson JE, Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-7.
22. Carry VJ, Walters EE, Colditz GA et al. Body fat distribution and risk of non-insulin dependent diabetes mellitus in women. The Nurses Health Study. Am J Epidemiol 1997; 145: 614-9.
23. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 96-9.
24. Knowler WC, Elizabeth B-C, Fowler SE et al. Diabetes Prevention Programme Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
25. Kadowaki T, Miyake Y, Hagura R et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44-49.
26. Laaksonen DE, Lindstrom J, Lakka TA et al. Physical activity in the prevention of type 2 diabetes the Finnish Diabetes Prevention Study. Diabetes 2005; 54: 158-65.
27. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49: 289-97.
28. Li G, Hu Y, Yang W et al. Chinese Da Qing Impaired Glucose Tolerance and Diabetes Study. Diabetes Res Clin Pract 2002; 58: 193-200.
29. Torgerson JS, Hauptman J, Boldrin MN, Lars Sjöström L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-61.
30. Overweight and Obesity: Obesity Trends: U.S. Obesity Trends 1985-2003. http://www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htm.
31. Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non-insulin dependent diabetes. In: National Diabetes Data Group, ed. Diabetes in America, 2nd edn. Washington, DC: U.S. Govt. Printing Office, 1995; pp. 47-67 (NIH publ. no. 95-1468).
32. Haris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults: The third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998; 21: 518-24.
33. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS. The continuing increase of diabetes in the US. Diabetes Care 2001; 24: 412.
34. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of obesity epidemic in the United States, 1991-1998. JAMA 1999; 282: 1519-22.
35. Mokdad AH, Ford ES, Bowman BA et al. Diabetes trends in the US, 1990-1998. Diabetes Care 2000; 23: 1278-83.
36. Ramachandran A, Snehalatha C, Kapur A et al. High prevalence of diabetes and impaired glucose tolerance in India. National Urban Diabetes Survey. Diabetologia 2001; 44: 1094-101.
37. Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan National Diabetes Survey: Prevalence of glucose intolerance and associated factors in Baluchistan Province. Diabetes Res Clin Prac 1999; 44: 49-58.
38. Sayeed MA, Hussain MZ, Banu A, Rumi MA, Azad Khan AK. Prevalence of diabetes in a suburban population of Bangladesh. Diabetes Res Clin Prac 1997; 34: 149-55.
39. Wijewardene K, Mohideen MR, Mendis S et al. Prevalence of hypertension, diabetes and obesity: Baseline findings of a population based survey in four provinces in Sri Lanka. Ceylon Med J 2005; 50: 62-70.
40. WHO. Prevalence of Diabetes. http://www.who.int/diabetes/actionnow/en/ mapdiabprev.pdf accessed on 06.09.2005, 2005.
41. Fernando DJ, Siribaddana S, de Silva D. Impaired glucose tolerance and diabetes mellitus in a suburban Sri Lankan community. Postgrad Med J 1994; 70: 347-9.
42. Mohanty SA, Woolhandler S, Himmelstein DU, Bor DH. Diabetes and cardiovascular disease among Asian Indians in the United States. J Gen Intern Med 2005; 20: 474-8.
43. Snehalatha C, Ramachandran A. Insulin resistance in Asian Indians. Prac Diabetes Int 1999; 16: 19-22.
44. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: Evidence and implications. Nutrition 2004; 20: 482-91.
45. Snehalatha C, Viswanathan V, Ramachandran A. Cut-off values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003; 26: 1380-4.
46. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 137-44.
47. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329-35.
48. 2) as a measure of fatness. International Journal of Obesity 1985; 9: 147-53.
49. The International Diabetes Federation (IDF) consensus worldwide definition of the metabolic syndrome, 2005, http://www/idf.org/webdata/ docs/idf Metabolic syndrome definition. PDF.
50. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. American Journal of Disease of Child 1991; 145: 259-63.
51. Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield, SB. Body mass index as a measure of adiposity among children and adolescents: A validation study. Journal of Paediatrics 1998; 132: 204-10.
52. World Health Organization. Obesity and Overweight. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/, accessed on 14.03.2006.
53. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO, 1998.
54. Warne DK, Charles MA, Hanson RL et al. Comparison of body size measurements as predictors of NIDDM in Pima Indians. Diabetes Care 1995; 18: 435-9,
55. Sargeant LA, Bennett FI, Forrester TE, Cooper RS, Wilks RJ. Predicting incident diabetes in Jamaica: The role of anthropometry. Obes Res 2002; 10: 792-8.
56. Kaye SA, Folsom AR, Sprafka JM, Prineas RJ, Wallace RB. Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 1991; 44: 329-34.
57. Carey VJ, Walters EE, Colditz GA et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women: The Nurses' Health Study. Am J Epidemiol 1997; 45: 614-9.
58. Pouliot MC, Despres JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-8.
59. Lemieux S, Prud'homme D, Tremblay A, Bouchard C, Despres JP. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int Obes Relat Metab Disord 1996; 20: 618-24.
60. National Heart, Lung, and Blood Institute/National Institutes of Diabetes and Digestive and Kidney Diseases. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. The Evidence Report. Bethesda, MD: National Institute of Health, 1998; pp. 1-228.